MARTA GRAVES: Open Payments
NPI 1346400975 · KALISPELL, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 28 payments from 13 companies in 2025. Trend: 2023 $2,277 · 2024 $2,203 · 2025 $596
Food & beverage: $586Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $160 |
| UCB, Inc. | 3 | $110 |
| GENZYME CORPORATION | 2 | $75 |
| Amgen Inc. | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
| BioWound Solutions, Inc. | 2 | $32 |
| LEO Pharma Inc. | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $25 |
| STRATA Skin Sciences, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
Products named: SKYRIZI, DUPIXENT, Bimzelx, OTEZLA, bio-ConneKt, ADBRY, Zoryve, RINVOQ.
Industry payments across MT — which companies pay providers there.
